Note: The following article synopsis was NOT provided by AAPC. It was created by Find-A-Code/innoviHealth.
Article Overview
This brief article explains a Centers for Medicare and Medicaid Services update to Medicare requirements tied to C-peptide testing. It is relevant to laboratory billing and coding professionals, compliance staff, and clinicians who document testing for diabetes-related coverage policies. The article focuses on the policy change, the affected date of service, and the general testing criteria involved.
Why This Topic Matters
Readers need to know when the CMS update applies and how the policy framework for this laboratory test changed, since documentation and medical necessity review may depend on current Medicare guidance.
What You Will Learn
What CMS updated in relation to C-peptide testing
What date the updated requirement applies to
What general testing criteria are discussed in the policy update
How the article frames Medicare-related laboratory coverage guidance
Who Should Read This
Medical coders
Billing staff
Compliance professionals
Laboratory personnel
Clinicians documenting test results for coverage
Subscribe or sign in to view the full article.
Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.
Fully searchable archives - over 5250 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.
Related Articles
Articles are listed in order of calculated relevance.